In CLL, SF3B1 mutation frequently co-occurs with two common CLL genetic lesions, del(13q) and del(17p), that result in ablation of the BCL2-targeting MIR15/16 locus and TP53, respectively (16, 41, 52). Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.